16-57903952-G-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001297.5(CNGB1):​c.2664C>A​(p.Ala888Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.112 in 1,613,682 control chromosomes in the GnomAD database, including 11,404 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A888A) has been classified as Benign.

Frequency

Genomes: 𝑓 0.15 ( 1967 hom., cov: 33)
Exomes 𝑓: 0.11 ( 9437 hom. )

Consequence

CNGB1
NM_001297.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -8.35

Publications

19 publications found
Variant links:
Genes affected
CNGB1 (HGNC:2151): (cyclic nucleotide gated channel subunit beta 1) In humans, the rod photoreceptor cGMP-gated cation channel helps regulate ion flow into the rod photoreceptor outer segment in response to light-induced alteration of the levels of intracellular cGMP. This channel consists of two subunits, alpha and beta, with the protein encoded by this gene representing the beta subunit. Defects in this gene are a cause of cause of retinitis pigmentosa type 45. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]
CNGB1 Gene-Disease associations (from GenCC):
  • CNGB1-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 45
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-57903952-G-T is Benign according to our data. Variant chr16-57903952-G-T is described in ClinVar as Benign. ClinVar VariationId is 93700.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.35 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.25 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNGB1NM_001297.5 linkc.2664C>A p.Ala888Ala synonymous_variant Exon 27 of 33 ENST00000251102.13 NP_001288.3
CNGB1NM_001286130.2 linkc.2646C>A p.Ala882Ala synonymous_variant Exon 27 of 33 NP_001273059.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNGB1ENST00000251102.13 linkc.2664C>A p.Ala888Ala synonymous_variant Exon 27 of 33 1 NM_001297.5 ENSP00000251102.8
CNGB1ENST00000564448.5 linkc.2646C>A p.Ala882Ala synonymous_variant Exon 27 of 33 1 ENSP00000454633.1
CNGB1ENST00000569643.1 linkn.321C>A non_coding_transcript_exon_variant Exon 3 of 6 5

Frequencies

GnomAD3 genomes
AF:
0.146
AC:
22158
AN:
152064
Hom.:
1964
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.254
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.148
Gnomad ASJ
AF:
0.0940
Gnomad EAS
AF:
0.0825
Gnomad SAS
AF:
0.123
Gnomad FIN
AF:
0.0484
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.105
Gnomad OTH
AF:
0.133
GnomAD2 exomes
AF:
0.117
AC:
29178
AN:
248746
AF XY:
0.113
show subpopulations
Gnomad AFR exome
AF:
0.264
Gnomad AMR exome
AF:
0.165
Gnomad ASJ exome
AF:
0.0909
Gnomad EAS exome
AF:
0.0818
Gnomad FIN exome
AF:
0.0523
Gnomad NFE exome
AF:
0.103
Gnomad OTH exome
AF:
0.104
GnomAD4 exome
AF:
0.108
AC:
158551
AN:
1461500
Hom.:
9437
Cov.:
55
AF XY:
0.108
AC XY:
78517
AN XY:
727052
show subpopulations
African (AFR)
AF:
0.261
AC:
8741
AN:
33470
American (AMR)
AF:
0.160
AC:
7156
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0937
AC:
2448
AN:
26130
East Asian (EAS)
AF:
0.0642
AC:
2549
AN:
39698
South Asian (SAS)
AF:
0.118
AC:
10176
AN:
86240
European-Finnish (FIN)
AF:
0.0536
AC:
2861
AN:
53398
Middle Eastern (MID)
AF:
0.118
AC:
673
AN:
5688
European-Non Finnish (NFE)
AF:
0.105
AC:
117240
AN:
1111802
Other (OTH)
AF:
0.111
AC:
6707
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
7737
15473
23210
30946
38683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4398
8796
13194
17592
21990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.146
AC:
22200
AN:
152182
Hom.:
1967
Cov.:
33
AF XY:
0.142
AC XY:
10591
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.254
AC:
10547
AN:
41514
American (AMR)
AF:
0.148
AC:
2265
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0940
AC:
326
AN:
3468
East Asian (EAS)
AF:
0.0819
AC:
423
AN:
5166
South Asian (SAS)
AF:
0.125
AC:
601
AN:
4820
European-Finnish (FIN)
AF:
0.0484
AC:
513
AN:
10602
Middle Eastern (MID)
AF:
0.133
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
0.105
AC:
7171
AN:
68012
Other (OTH)
AF:
0.134
AC:
283
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
900
1801
2701
3602
4502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.105
Hom.:
3683
EpiCase
AF:
0.100
EpiControl
AF:
0.101

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Oct 23, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Retinal dystrophy Benign:1
Jan 01, 2013
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.030
DANN
Benign
0.31
PhyloP100
-8.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs413562; hg19: chr16-57937856; API